English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

lowing: Bausch & Lomb Inc, Notal Vision, Novartis Pharma AG, Roche/Genentech Inc, and Regeneron Pharmaceuticals Inc. Dr N. M. Bressler is a principal investigator of grants at Johns Hopkins University sponsored by the following: Abbott Medical Optics Inc, Alimera Sciences, Allergan USA, Inc, Bausch & Lomb Inc, Carl Zeiss Meditec Inc, ForSight Labs, LLC, Genzyme Corp, Lumenis Inc, Notal Vision, Novartis Pharma AG, Pfizer Inc, QLT Inc, Regeneron Pharmaceuticals Inc, Roche/ Genentech Inc, Steba Biotech SA, and The EMMES Corp. Funding/Support: This work was supported by Research to Prevent Blindness (Dr N. M. Bressler), the James P. Gills Professorship (Dr N. M. Bressler), the Julia G. Levy, PhD Professorship (Dr S. B. Bressler), and unrestricted donations to the Retina Division of the Wilmer Eye Institute.

Intravitreous Tissue Plasminogen Activator With Pneumatic Displacement in Submacular Hemorrhage